US Stock MarketDetailed Quotes

APLT Applied Therapeutics

Watchlist

0.867
-0.013-1.52%

Close Dec 23 16:00 ET

0.844
-0.023-2.63%

Post 16:11 ET

100.85MMarket Cap-0.61P/E (TTM)

Applied Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

122K

144K

-98.22%190K

9.99M

-667K

10.66M

Operating revenue

--122K

--144K

-98.22%190K

--9.99M

---667K

--0

--10.66M

--0

Cost of revenue

Gross profit

Operating expense

92.74%29.87M

19.84%20.58M

-1.09%21.28M

-10.15%74.53M

7.22%20.34M

-19.95%15.5M

-20.19%17.18M

-6.85%21.52M

-21.46%82.95M

-30.03%18.97M

Selling and administrative expenses

219.26%15.04M

99.89%10.58M

62.39%9.07M

-24.50%20.62M

-26.77%5.04M

-24.52%4.71M

-13.58%5.29M

-30.83%5.58M

-36.55%27.32M

-39.60%6.88M

-General and administrative expense

219.26%15.04M

99.89%10.58M

62.39%9.07M

-24.50%20.62M

-26.77%5.04M

-24.52%4.71M

-13.58%5.29M

-30.83%5.58M

-36.55%27.32M

-39.60%6.88M

Research and development costs

37.49%14.83M

-15.81%10M

-23.33%12.22M

-3.11%53.91M

26.55%15.3M

-17.77%10.79M

-22.82%11.88M

6.02%15.94M

-11.09%55.63M

-23.10%12.09M

Operating profit

-91.95%-29.74M

-19.00%-20.44M

-94.26%-21.09M

22.20%-64.54M

-10.73%-21.01M

19.95%-15.5M

20.19%-17.18M

53.00%-10.86M

21.46%-82.95M

30.03%-18.97M

Net non-operating interest income expense

246.17%1.36M

53.92%628K

165.16%586K

100.29%1.37M

29.89%352K

72.69%392K

267.57%408K

190.79%221K

23.42%685K

15.81%271K

Non-operating interest income

246.17%1.36M

53.92%628K

165.16%586K

100.29%1.37M

29.89%352K

72.69%392K

267.57%408K

190.79%221K

--685K

--271K

Other net income (expense)

-47.45%-40.21M

277.30%22.71M

-12,786.20%-63.43M

-23,192.18%-56.6M

-498.48%-17.02M

-97,482.14%-27.27M

-188.04%-12.81M

620.83%500K

53.36%-243K

1,631.18%4.27M

Gain on sale of security

-47.32%-40.18M

277.63%22.74M

-13,619.19%-63.41M

-85,616.67%-56.57M

-498.64%-16.96M

-75,869.44%-27.28M

-193.87%-12.8M

--469K

---66K

--4.26M

Other non- operating income (expenses)

-310.00%-21K

-580.00%-34K

-183.87%-26K

84.75%-27K

-458.82%-61K

225.00%10K

94.44%-5K

132.29%31K

66.03%-177K

106.09%17K

Income before tax

-61.89%-68.59M

109.80%2.9M

-728.04%-83.94M

-45.15%-119.76M

-161.13%-37.68M

-121.82%-42.37M

-14.39%-29.58M

56.16%-10.14M

21.86%-82.51M

46.87%-14.43M

Income tax

Net income

-61.89%-68.59M

109.80%2.9M

-728.04%-83.94M

-45.15%-119.76M

-161.13%-37.68M

-121.82%-42.37M

-14.39%-29.58M

56.16%-10.14M

21.86%-82.51M

46.87%-14.43M

Net income continuous Operations

-61.89%-68.59M

109.80%2.9M

-728.04%-83.94M

-45.15%-119.76M

-161.13%-37.68M

-121.82%-42.37M

-14.39%-29.58M

56.16%-10.14M

21.86%-82.51M

46.87%-14.43M

Minority interest income

Net income attributable to the parent company

-61.89%-68.59M

109.80%2.9M

-728.04%-83.94M

-45.15%-119.76M

-161.13%-37.68M

-121.82%-42.37M

-14.39%-29.58M

56.16%-10.14M

21.86%-82.51M

46.87%-14.43M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-61.89%-68.59M

109.80%2.9M

-728.04%-83.94M

-45.15%-119.76M

-161.13%-37.68M

-121.82%-42.37M

-14.39%-29.58M

56.16%-10.14M

21.86%-82.51M

46.87%-14.43M

Basic earnings per share

-2.13%-0.48

105.41%0.02

-272.22%-0.67

34.86%-1.42

-106.25%-0.33

-17.50%-0.47

61.46%-0.37

79.55%-0.18

47.09%-2.18

84.62%-0.16

Diluted earnings per share

-2.13%-0.48

64.86%-0.13

-272.22%-0.67

34.86%-1.42

-106.25%-0.33

-17.50%-0.47

61.46%-0.37

79.55%-0.18

47.09%-2.18

84.62%-0.16

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	122K	144K	-98.22%190K	9.99M	-667K	0	0	10.66M	0	0
Operating revenue	--122K	--144K	-98.22%190K	--9.99M	---667K	--0	--0	--10.66M	--0	--0
Cost of revenue
Gross profit
Operating expense	92.74%29.87M	19.84%20.58M	-1.09%21.28M	-10.15%74.53M	7.22%20.34M	-19.95%15.5M	-20.19%17.18M	-6.85%21.52M	-21.46%82.95M	-30.03%18.97M
Selling and administrative expenses	219.26%15.04M	99.89%10.58M	62.39%9.07M	-24.50%20.62M	-26.77%5.04M	-24.52%4.71M	-13.58%5.29M	-30.83%5.58M	-36.55%27.32M	-39.60%6.88M
-General and administrative expense	219.26%15.04M	99.89%10.58M	62.39%9.07M	-24.50%20.62M	-26.77%5.04M	-24.52%4.71M	-13.58%5.29M	-30.83%5.58M	-36.55%27.32M	-39.60%6.88M
Research and development costs	37.49%14.83M	-15.81%10M	-23.33%12.22M	-3.11%53.91M	26.55%15.3M	-17.77%10.79M	-22.82%11.88M	6.02%15.94M	-11.09%55.63M	-23.10%12.09M
Operating profit	-91.95%-29.74M	-19.00%-20.44M	-94.26%-21.09M	22.20%-64.54M	-10.73%-21.01M	19.95%-15.5M	20.19%-17.18M	53.00%-10.86M	21.46%-82.95M	30.03%-18.97M
Net non-operating interest income expense	246.17%1.36M	53.92%628K	165.16%586K	100.29%1.37M	29.89%352K	72.69%392K	267.57%408K	190.79%221K	23.42%685K	15.81%271K
Non-operating interest income	246.17%1.36M	53.92%628K	165.16%586K	100.29%1.37M	29.89%352K	72.69%392K	267.57%408K	190.79%221K	--685K	--271K
Other net income (expense)	-47.45%-40.21M	277.30%22.71M	-12,786.20%-63.43M	-23,192.18%-56.6M	-498.48%-17.02M	-97,482.14%-27.27M	-188.04%-12.81M	620.83%500K	53.36%-243K	1,631.18%4.27M
Gain on sale of security	-47.32%-40.18M	277.63%22.74M	-13,619.19%-63.41M	-85,616.67%-56.57M	-498.64%-16.96M	-75,869.44%-27.28M	-193.87%-12.8M	--469K	---66K	--4.26M
Other non- operating income (expenses)	-310.00%-21K	-580.00%-34K	-183.87%-26K	84.75%-27K	-458.82%-61K	225.00%10K	94.44%-5K	132.29%31K	66.03%-177K	106.09%17K
Income before tax	-61.89%-68.59M	109.80%2.9M	-728.04%-83.94M	-45.15%-119.76M	-161.13%-37.68M	-121.82%-42.37M	-14.39%-29.58M	56.16%-10.14M	21.86%-82.51M	46.87%-14.43M
Income tax
Net income	-61.89%-68.59M	109.80%2.9M	-728.04%-83.94M	-45.15%-119.76M	-161.13%-37.68M	-121.82%-42.37M	-14.39%-29.58M	56.16%-10.14M	21.86%-82.51M	46.87%-14.43M
Net income continuous Operations	-61.89%-68.59M	109.80%2.9M	-728.04%-83.94M	-45.15%-119.76M	-161.13%-37.68M	-121.82%-42.37M	-14.39%-29.58M	56.16%-10.14M	21.86%-82.51M	46.87%-14.43M
Minority interest income
Net income attributable to the parent company	-61.89%-68.59M	109.80%2.9M	-728.04%-83.94M	-45.15%-119.76M	-161.13%-37.68M	-121.82%-42.37M	-14.39%-29.58M	56.16%-10.14M	21.86%-82.51M	46.87%-14.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-61.89%-68.59M	109.80%2.9M	-728.04%-83.94M	-45.15%-119.76M	-161.13%-37.68M	-121.82%-42.37M	-14.39%-29.58M	56.16%-10.14M	21.86%-82.51M	46.87%-14.43M
Basic earnings per share	-2.13%-0.48	105.41%0.02	-272.22%-0.67	34.86%-1.42	-106.25%-0.33	-17.50%-0.47	61.46%-0.37	79.55%-0.18	47.09%-2.18	84.62%-0.16
Diluted earnings per share	-2.13%-0.48	64.86%-0.13	-272.22%-0.67	34.86%-1.42	-106.25%-0.33	-17.50%-0.47	61.46%-0.37	79.55%-0.18	47.09%-2.18	84.62%-0.16
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Heat List

Overall

No Data